Study: GLP-1 weight-loss drug found to slow biological ageing in female mice
Researchers testing a GLP-1 receptor agonist, the class of drug behind popular weight-loss treatments, observed that female mice given the compound showed slower markers of biological ageing compared to untreated mice. The effect was notably more pronounced in females than in males in the study.